Global Thoracic Outlet Syndrome Market, By Type (Neurogenic Thoracic Outlet Syndrome, Venous Thoracic Outlet Syndrome, Arterial Thoracic Outlet Syndrome), Treatment (Surgery, Medications, Physical Therapy, Others), Diagnosis (Nerve Conduction Studies, Vascular Studies, Chest X-Ray, Cervical Spine X-Rays, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Magnetic Resonance Imaging With Angiography (MRA), Arteriogram/Venogram, Blood Tests), Dosage (Injection, Tablets, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Thoracic Outlet Syndrome Market
Thoracic outlet syndrome market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.30% in the above mentioned forecast period.
Thoracic outlet syndrome (TOC) is a collection of illnesses that produce numbness and tingling in the fingers, as well as pain in the neck, shoulder, and arms. The compression of blood vessels and nerves in the thoracic outlet (the region between the collarbone and the first rib) causes thoracic outlet syndrome. Damage to the shoulder or neck, anatomical anomalies, accidents from sports-related activities, obesity and chest tumours are all typical causes of thoracic outlet syndrome. Vascular, neurogenic and non-specific thoracic outlet syndromes are the three forms of thoracic outlet syndromes. Therapeutic medications such as anti-inflammatory drugs, anti-coagulation drugs, and muscle relaxants are used to treat thoracic outlet syndrome. When medical treatment fails to alleviate the symptoms of thoracic outlet syndrome, surgical procedures are used to relieve the pain.
The rise in the prevalence of thoracic outlet syndrome is the major driver resulting in the expansion of market’s growth. Another significant factor influencing the growth rate of thoracic outlet syndrome market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, growing government funding and rising initiatives by public and private organisations to spread awareness are the factors that will expand the thoracic outlet syndrome market. Other factors such as increase in the level of disposable income and growing cases of anatomical defects will positively impact the thoracic outlet syndrome market’s growth rate. Additionally, improvements associated with reimbursement policies will result in the expansion of thoracic outlet syndrome market.
Moreover, the rise in the research and development activities and high unmet need of current treatment will provide beneficial opportunities for the thoracic outlet syndrome market in the forecast period of 2022-2029. Also, developments in the healthcare technology will escalate the growth rate thoracic outlet syndrome market in future.
However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of thoracic outlet syndrome market. Additionally, complications involved with thoracic outlet syndrome will hinder the thoracic outlet syndrome market growth. Less awareness about thoracic outlet syndrome will further challenge the market in the forecast period mentioned above.
This thoracic outlet syndrome market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the thoracic outlet syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Thoracic Outlet Syndrome Market Scope and Market Size
The thoracic outlet syndrome market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the thoracic outlet syndrome market is segmented into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.
- On the basis of treatment, the thoracic outlet syndrome market is segmented into surgery, medications, physical therapy and others. The medication segment is further sub-segmented into non-steroidal anti-inflammatory drugs (NSAID), skeletal muscle relaxants, anticoagulants, and botulinum toxin therapeutics.
- On the basis of diagnosis, the thoracic outlet syndrome market is segmented into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, computed tomography (CT) scan, magnetic resonance imaging (MRI), magnetic resonance imaging with angiography (MRA), arteriogram/venogram, and blood tests.
- On the basis of dosage, the thoracic outlet syndrome market is segmented into injection, tablets and others.
- On the basis of route of administration, the thoracic outlet syndrome market is segmented into oral, parenteral and others.
- On the basis of end-users, the thoracic outlet syndrome market is segmented into clinic, hospital and others.
The thoracic outlet syndrome market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Thoracic Outlet Syndrome Market Country Level Analysis
Thoracic outlet syndrome market is analyzed and market size information is provided by the country, type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the thoracic outlet syndrome market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the thoracic outlet syndrome market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Thoracic outlet syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Thoracic Outlet Syndrome Market Share Analysis
Thoracic outlet syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to thoracic outlet syndrome market research.
Some of the major players operating in the thoracic outlet syndrome market are Piramal Critical Care, Validus Pharmaceuticals LLC, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi, Abbott, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Mallinckrodt, Johnson & Johnson Private Limited, Endo International plc, Boehringer Ingelheim International GmbH., Apotex Inc., Mylan N.V., Allergan, Takeda Pharmaceutical Company Limited., Oriental Pharma, and DAIICHI SANKYO COMPANY, LIMITED., among others.
SKU-